InsiderTrades

Form 4 for HAE HAEMONETICS CORP

Accepted 2024-05-21 00:00:00 ET · period of report 2024-05-17 · accession 0001127602-24-016169 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
M 2024-05-21 2024-05-17+ HAE Llorens Josep EVP, Gbl Manufacturing S - Sale $94.96 -1,809 21.3K -8% -$171.8K
2024-05-21 2024-05-17 HAE Llorens Josep EVP, Gbl Manufacturing A - Grant — +6,267 22.3K +39% —
2024-05-21 2024-05-17 HAE Llorens Josep EVP, Gbl Manufacturing F - Tax $95.73 -320 16.0K -2% -$30.6K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-05-17 S D 822 $94.82 16,350 D — — (F2) This number includes unvested restricted stock units ("RSUs") previously reported.
2 Common Common Stock 2024-05-20 S D 987 $95.08 21,310 D — — (F2) This number includes unvested restricted stock units ("RSUs") previously reported.
3 Common Common Stock 2024-05-17 A A 6,267 — 22,297 D — — (F4) The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant. (F5) Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. (F2) This number includes unvested restricted stock units ("RSUs") previously reported.
4 Common Common Stock 2024-05-17 F D 320 $95.73 16,030 D — — (F3) Represents shares withheld for tax obligations in connection with the vesting of certain RSUs previously reported in Table I. (F2) This number includes unvested restricted stock units ("RSUs") previously reported.